Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y0WW
|
|||
Former ID |
DIB002645
|
|||
Drug Name |
FM-303
|
|||
Synonyms |
IL-23 antagonist (ATLAb antibody technology, IBD), Femta Pharmaceuticals
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Inflammatory bowel disease [ICD-11: DD72; ICD-10: K50-K52] | Investigative | [1] | |
Company |
Femta Pharmaceuticals Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin 23 receptor (IL23R) | Target Info | . | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Jak-STAT signaling pathway | ||||
Inflammatory bowel disease (IBD) | ||||
Pathway Interaction Database | IL23-mediated signaling events |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2293). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.